Harrow Health to Announce First Quarter 2021 Financial Results on May 11, 2021
27 avr. 2021 09h00 HE
|
Harrow Health, Inc.
NASHVILLE, Tenn., April 27, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that it will release its financial results for the...
Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026
20 avr. 2021 16h01 HE
|
Harrow Health, Inc.
NASHVILLE, Tenn., April 20, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the closing of...
Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026
15 avr. 2021 17h00 HE
|
Harrow Health, Inc.
NASHVILLE, Tenn., April 15, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the pricing of...
Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones
14 avr. 2021 16h01 HE
|
Harrow Health, Inc.
NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced it has commenced an underwritten registered public...
Harrow Health Announces Preliminary First Quarter 2021 Financial Results
14 avr. 2021 16h00 HE
|
Harrow Health, Inc.
NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced certain preliminary unaudited financial results for...
Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results
08 mars 2021 16h01 HE
|
Harrow Health, Inc.
Highlights for Fourth Quarter 2020: Revenues of $14.6 million, a 16% increase compared with $12.6 million for prior year;Adjusted EBITDA reached a new high of $4.0 million, compared with $2.1 million...
Harrow Health to Participate in H.C. Wainwright Global Life Sciences Conference
02 mars 2021 09h00 HE
|
Harrow Health, Inc.
NASHVILLE, Tenn., March 02, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that Mark Baum, Chief Executive Officer, and Andrew...
Harrow Health to Announce Fourth Quarter and Year-End 2020 Financial Results on March 8, 2021
25 févr. 2021 09h00 HE
|
Harrow Health, Inc.
NASHVILLE, Tenn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that it will release its financial results for the...
Study on Patented Non-Opioid MKO Melt® Reported in Leading Peer-Reviewed Anesthesia Journal
03 déc. 2020 07h30 HE
|
Harrow Health, Inc.
NASHVILLE, Tenn., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that a study featuring its patented MKO Melt® formulation has been published in the American...
Harrow Health Announces Participation at the Piper Sandler 32nd Annual Healthcare Conference
20 nov. 2020 07h30 HE
|
Harrow Health, Inc.
NASHVILLE, Tenn., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that Mark Baum, Harrow’s Chief Executive Officer, and Andrew Boll, Harrow’s Chief Financial...